Abstract
Retinoids that activate the nuclear retinoid X receptors (RXRs) display potential for chemoprevention of breast cancer. We previously reported that 9cUAB30 (1) is an RXR-selective retinoid. To explore its in vivo chemopreventive activity, multigram quantities of 1 were needed. Here, we describe a modified synthesis that yields up to 100 g of 1. We further demonstrate that 1 is very effective in the prevention of N-methyl-N-nitrosourea induced mammary cancers in rats without signs of toxicity.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Anticarcinogenic Agents / chemical synthesis*
-
Anticarcinogenic Agents / chemistry
-
Anticarcinogenic Agents / pharmacology
-
Drug Screening Assays, Antitumor
-
Fatty Acids, Unsaturated / chemical synthesis*
-
Fatty Acids, Unsaturated / chemistry
-
Fatty Acids, Unsaturated / pharmacology
-
Female
-
Mammary Neoplasms, Experimental / prevention & control*
-
Naphthalenes / chemical synthesis*
-
Naphthalenes / chemistry
-
Naphthalenes / pharmacology
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, Retinoic Acid / agonists
-
Retinoid X Receptors
-
Stereoisomerism
-
Transcription Factors / agonists
-
Tretinoin / analogs & derivatives*
-
Tretinoin / chemical synthesis*
-
Tretinoin / pharmacology
Substances
-
Anticarcinogenic Agents
-
Fatty Acids, Unsaturated
-
Naphthalenes
-
Receptors, Retinoic Acid
-
Retinoid X Receptors
-
Transcription Factors
-
Tretinoin
-
UAB 30